References
- ServiceMWMedical Entomology for StudentsLondonChapman and Hall1996
- OrkinMScabies: what’s new?Curr Probl Dermatol1995221051117587311
- ChosidowOScabiesN Engl J Med2006354161718172716625010
- PannellRFlemingDCrossKThe incidence of molluscum contagiosum, scabies and lichen planusEpidemiol Infect2005133698599116274495
- HayRSteerAEngelmanDWaltonSScabies in the developing world – its prevalence, complications, and managementClin Microbiol Infect201218431332322429456
- DownsAHarveyIKennedyCThe epidemiology of head lice and scabies in the UKEpidemiol Infect1999122347147710459652
- DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
- ChenJCManninoDMWorldwide epidemiology of chronic obstructive pulmonary diseaseCurr Opin Pulm Med199952939910813258
- ChengSLChanMCWangCCCOPD in Taiwan: a National Epidemiology SurveyInt J Chron Obstruct Pulmon Dis2015102459246726648708
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPD2016 Available from: http://www.goldcopd.org/Accessed August 11, 2016
- SalviSSBarnesPJChronic obstructive pulmonary disease in nonsmokersLancet2009374969173374319716966
- MenezesAMPerez-PadillaRJardimJBPLATINO TeamChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
- ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000MMWR Surveill Summ2002516116
- DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- WangCHLeeSCHuangSSKaoYCSeeLCYangSHRisk factors for scabies in TaiwanJ Microbiol Immunol Infect201245427628022444547
- ChengTMReflections on the 20th anniversary of Taiwan’s single-payer national health insurance systemHealth Aff2015343502510
- National Health Research InstitutesNational Health Insurance Research Database Available from: http://nhird.nhri.org.tw/en/Data_Subsets.html#S3Accessed October 1, 2013
- US Department of Health and Human Services PHS, Health Care Financing AdministrationThe International Classification of Diseases: 9th Revision, Clinical Modification: ICD-9-CMWashington, DCUS Department of Health and Human Services1989
- LiuCYHungYTChuangYLIncorporating development stratification of Taiwan townships into sampling design of large scale health interview surveyJ Health Manag20064122
- ArlianLGMorganMSNealJSModulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mitesAm J Trop Med Hyg200369665265614740884
- BarnesPJShapiroSPauwelsRChronic obstructive pulmonary disease: molecular and cellularmechanismsEur Respir J200322467268814582923
- KeatingsVMCollinsPDScottDMBarnesPJDifferences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med199615325305348564092
- HoshinoHLaanMSjöstrandMLötvallJSkooghBELindénAIncreased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivoJ Allergy ClinImmunol20001051 pt 1143149
- TanHLRosenthalMIL-17 in lung disease: friend or foe?Thorax201368878879023604380
- ChenKPociaskDAMcAleerJPIL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smokePLoS One201165e2033321647421
- WaltonSFThe immunology of susceptibility and resistance to scabiesParasite Immunol201032853254020626808
- LiuXWaltonSFMurrayHCCrusted scabies is associated with increased IL-17 secretion by skin T cellsParasite Immunol2014361159460425040151
- BozinovskiSVlahosRMultifaceted role for IL-17A in the pathogenesis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015191111213121426029829
- HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
- LindbergAJonssonACRönmarkELundgrenRLarssonLGLundbäckBTen-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohortChest200512751544155215888826
- ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
- MillerJEdwardsLDAgustíAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsComorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespir Med201310791376138423791463
- HavranekEPMasoudiFAWestfallKAWolfePOrdinDLKrumholzHMSpectrum of heart failure in older patients: results from the National Heart Failure projectAm Heart J2002143341241711868045
- EhrlichSFQuesenberryCPVan Den EedenSKShanJFerraraAPatients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancerDiabetes Care2010331556019808918